Case number 2023-1460
Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 25, 2023 | 27 | REPLY BRIEF FILED by Cross-Appellant Fresenius Kabi USA, LLC. Service: 08/25/2023 by email. (PENDING COMPLIANCE REVIEW) [946052] [23-1460] [Imron Aly] [Entered: 08/25/2023 03:59 PM] (28) |
| Jul 31, 2023 | 26 | **TEXT ONLY** ORDER granting motion to extend time to file brief [25] filed by Cross-Appellant Fresenius Kabi USA, LLC. Cross-Appellant's reply brief is due 08/25/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [939455] --[Edited 07/31/2023 by CAB to revise docket text] [JPS] [Entered: 07/31/2023 11:02 AM] (0) |
| Jul 28, 2023 | 25 | MOTION of Cross-Appellant Fresenius Kabi USA, LLC to extend the time to 08/25/2023 to file brief. Service: 07/28/2023 by email. [939268] [23-1460] [Joel Wallace] [Entered: 07/28/2023 03:23 PM] (9) |
| Jul 24, 2023 | 24 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 07/24/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [938200] --[Edited 08/15/2023 by CAB - compliance review complete] [Mary Bourke] [Entered: 07/24/2023 05:20 PM] (73) |
| Jun 6, 2023 | 20 | MOTION of Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S to extend the time to 07/24/2023 to file brief. Service: 06/06/2023 by email. [928065] [23-1460] [Mary Bourke] [Entered: 06/06/2023 12:38 PM] (5) |
| Jun 6, 2023 | 21 | Certificate of Interest for Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 06/06/2023 by email. [928075] [23-1460] [Mary Bourke] [Entered: 06/06/2023 01:18 PM] (3) |
| Jun 6, 2023 | 22 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Appellants' Motion for Extension of Time [20] was split across multiple entries. For future filings, a single filing (including supporting attachments) submitted through the court's electronic filing system must be filed and served in one event. Fed. R. App. P. 27(a)(2)(B)(i). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [928097] [CMH] [Entered: 06/06/2023 01:56 PM] (0) |
| Jun 6, 2023 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file brief [20] filed by Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. The reply brief is due 07/24/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [928102] [CMH] [Entered: 06/06/2023 02:09 PM] (0) |
| May 30, 2023 | 19 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Cross-Appellant Fresenius Kabi USA, LLC. Service: 05/30/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [926649] --[Edited 07/06/2023 by CAB - compliance review complete] [Imron Aly] [Entered: 05/30/2023 04:40 PM] (88) |
| May 3, 2023 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file brief [17] filed by Cross-Appellant Fresenius Kabi USA, LLC. The response brief is due 05/30/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [920780] [CMH] [Entered: 05/03/2023 10:53 AM] (0) |
| Apr 28, 2023 | 17 | MOTION of Cross-Appellant Fresenius Kabi USA, LLC to extend the time to 05/30/2023 to file brief. Service: 04/28/2023 by email. [920008] [23-1460] [Joel Wallace] [Entered: 04/28/2023 09:59 PM] (8) |
| Apr 4, 2023 | 15 | Amended Certificate of Interest for Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 04/04/2023 by email. [914465] [23-1460] [Mary Bourke] [Entered: 04/04/2023 05:27 PM] (3) |
| Apr 4, 2023 | 16 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 04/04/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [914467] --[Edited 04/17/2023 by CMH - compliance review complete] [Mary Bourke] [Entered: 04/04/2023 05:31 PM] (383) |
| Mar 9, 2023 | 13 | ORDER consolidating appeals (23-1460 and 23-1559). The revised official caption is reflected in the order. (See order for additional details). Service as of this date by the Clerk of Court. [908983] [23-1460, 23-1559] [MMA] [Entered: 03/09/2023 04:43 PM] (2) |
| Mar 9, 2023 | 14 | Note to File: The following cases are consolidated: 23-1460 (Lead) with 23-1559 (Cross-Appeal). The parties must file all documents in the lead appeal only. [908986] [23-1460, 23-1559] [MMA] [Entered: 03/09/2023 04:50 PM] (0) |
| Mar 6, 2023 | 11 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Fresenius Kabi USA, LLC, Entry of Appearance [8], is not in compliance with the rules of this court (see attached). Compliant document due on 03/13/2023. Service as of this date by the Clerk of Court. [908076] [MMA] [Entered: 03/06/2023 05:08 PM] (1) |
| Mar 6, 2023 | 12 | Corrected Entry of Appearance for Imron T. Aly; Joel M. Wallace; Jason G. Harp as counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/06/2023 by email. [908085] [23-1460] [Joel Wallace] [Entered: 03/06/2023 05:31 PM] (2) |
| Feb 28, 2023 | 7 | Notice to Appellee Fresenius Kabi USA, LLC: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Please file promptly. Service as of this date by the Clerk of Court. [906912] [MMA] [Entered: 02/28/2023 04:03 PM] (0) |
| Feb 28, 2023 | 8 | Entry of Appearance for Imron T. Aly; Joel M. Wallace; Jason G. Harp as counsel for Appellee Fresenius Kabi USA, LLC. Service: 02/28/2023 by email. [906991] [23-1460] This document is non-compliant. See Doc No. [11] [Joel Wallace] [Entered: 02/28/2023 10:04 PM] (2) |
| Feb 28, 2023 | 9 | Certificate of Interest for Appellee Fresenius Kabi USA, LLC. Service: 02/28/2023 by email. [906992] [23-1460] [Joel Wallace] [Entered: 02/28/2023 10:07 PM] (4) |
| Feb 28, 2023 | 10 | Docketing Statement for the Appellee Fresenius Kabi USA, LLC. Service: 02/28/2023 by email. [906993] [23-1460] [Joel Wallace] [Entered: 02/28/2023 10:09 PM] (2) |
| Feb 27, 2023 | 6 | Corrected Certificate of Interest for Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 02/27/2023 by email. [906615] [23-1460] [Mary Bourke] [Entered: 02/27/2023 04:23 PM] (3) |
| Feb 23, 2023 | 5 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S, Certificate of Interest [3], is not in compliance with the rules of this court (see attached). Compliant document due on 03/02/2023. Service as of this date by the Clerk of Court. [905924] [CMH] [Entered: 02/23/2023 03:08 PM] (1) |
| Feb 17, 2023 | 2 | Entry of Appearance for Mary W. Bourke (principal counsel); Dana K. Severance; John B. Bourke; Christian E. Mammen; Joshua P. Davis as counsel for Appellants Ferring Pharmaceuticals Inc., Ferring International Center SA, Ferring B.V. and Polypeptide Laboratories A/S. Service: 02/17/2023 by email. [904956] [23-1460] [Mary Bourke] [Entered: 02/17/2023 04:42 PM] (2) |
| Feb 17, 2023 | 3 | Certificate of Interest for Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 02/17/2023 by email. [904959] [23-1460] This document is non-compliant. See Doc No. [5] [Mary Bourke] [Entered: 02/17/2023 04:46 PM] (3) |
| Feb 17, 2023 | 4 | Docketing Statement for the Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 02/17/2023 by email. [904963] [23-1460] [Mary Bourke] [Entered: 02/17/2023 04:49 PM] (2) |
| Feb 3, 2023 | 1 | Appeal docketed. Received: 01/30/2023. [901875]Entry of Appearance is due on 02/17/2023. Certificate of Interest is due on 02/17/2023. Docketing Statement is due on 02/17/2023. Appellants' brief is due 04/04/2023. [CMH] [Entered: 02/03/2023 03:20 PM] (134) |
